Kroger Specialty Pharmacy, Inc.
FDA Regulatory Profile
Summary
- Total Recalls
- 67
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|
| D-0763-2018 | Class II | Cimzia 200 mg/mL PFS Kit #2 NDC 50474-0710-79 28 days supply. | April 3, 2018 |
| D-0759-2018 | Class II | Vosevi 400/100/100 mg Tablets #28 NDC 61958-2401-01 28 days supply. | April 3, 2018 |
| D-0748-2018 | Class II | Prolia 60 mg/1 mL PF syringe NDC 55513-0710-01 180 days supply. | April 3, 2018 |
| D-0757-2018 | Class II | Sodium Chloride 3% Inh. 4 mL NEP #30 NDC 00487-9003-60 30 days supply. | April 3, 2018 |
| D-0762-2018 | Class II | Stelara 90 mg/MI PFS NDC 57894-0061-03 84 days supply | April 3, 2018 |
| D-0777-2018 | Class II | Ibrance 125 mg cap NDC 00069-0189-21 28 days supply | April 3, 2018 |
| D-0734-2018 | Class II | Humira Pen Sub-q Kit a.) 40 mg/0.8 mL (NDC 00074-4339-02); Humira Pen Psor Kit b.) 40 mg/0.8 mL (NDC | April 3, 2018 |
| D-0743-2018 | Class II | Altera Handset NDC 83490-0678-05 56 days supply | April 3, 2018 |
| D-0776-2018 | Class II | Avonex 30 mcg/0.5 mL PFS Kit NDC 59627-0222-05 28 days supply | April 3, 2018 |
| D-0742-2018 | Class II | Cosentyx 150 mg/mL PFS 300 mg Dose NDC 00078-0639-98, 28 days supply | April 3, 2018 |
| D-0750-2018 | Class II | Orkambi 200 mg/125 mg Tablets #112 NDC 51167-0809-01 28 days supply. | April 3, 2018 |
| D-0746-2018 | Class II | Enbrel PFS 50 mg/mL Inj #4 NDC 58406-0435-04 28 days supply; | April 3, 2018 |
| D-0788-2018 | Class II | Sutent 50 mg capsules x28 NDC 00069-0550-38 42 days supply | April 3, 2018 |
| D-0784-2018 | Class II | Sprycel 100 mg tablet NDC 00003-0852-22 30 days supply | April 3, 2018 |
| D-0749-2018 | Class II | Kitabis Pak 300 mg/5 mL Soln PARI #56 NDC 24492-0850-56 56 days supply | April 3, 2018 |
| D-0761-2018 | Class II | Boost VHC Oral Liquid VAN #27 NDC 43900-0182-15 27 days supply | April 3, 2018 |
| D-0737-2018 | Class II | Pediasure Liq. Vanilla G+G (CAN) #24 24 days supply, NDC 70074-0558-98 | April 3, 2018 |
| D-0789-2018 | Class II | Imatinib Mesylate Tablet 400 mg NDC 60505-2901-03 30 days supply | April 3, 2018 |
| D-0741-2018 | Class II | Taltz 80 mg/mL Pen 1-pk NDC 00002-1445-11 28 days supply | April 3, 2018 |
| D-0797-2018 | Class II | Tasigna Capsules 150 mg NDC 00078-0592-87 28 days supply | April 3, 2018 |